[Source: Research & Innovation] An innovative Swedish SME will soon launch a life-saving test for one of the most lethal and hard-to-detect forms of cancer. Clinically validated in an EU-funded project, the test could revolutionise the diagnosis of pancreatic cancer, providing early detection with unprecedented accuracy, boosting patient survival rates and enabling widespread screening of high-risk groups.
from EUROPA - Syndicated Research News Feed https://ift.tt/2OtW4a2
via IFTTT
No comments:
Post a Comment